Characterization of Bladder Selectivity of Antimuscarinic Agents on the Basis of In Vivo Drug-Receptor Binding

Samankaltaisia teoksia

• Direct in vitro and in vivo demonstration of muscarinic receptor binding by the novel radioligand, [3H]5-hydroxymethyltolterodine, in the bladder and other tissues of rats
  Tekijä: Shizuo Yamada, et al.
  Julkaistu: (2020-03-01)
• Characterization of muscarinic receptor binding by the novel radioligand, [3H]imidafenacin, in the bladder and other tissues of rats
  Tekijä: Shiori Kuraoka, et al.
  Julkaistu: (2016-07-01)
• α(1)-Adrenoceptors and muscarinic receptors in voiding function – binding characteristics of therapeutic agents in relation to the pharmacokinetics
  Tekijä: Yamada, Shizuo, et al.
  Julkaistu: (2011)
• Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice
  Tekijä: Oki, Tomomi, et al.
  Julkaistu: (2005)
• Alzheimer’s disease and related dementias risk: Comparing users of non-selective and M3-selective bladder antimuscarinic drugs
  Tekijä: Barthold, Douglas, et al.
  Julkaistu: (2020)